Profil
Kolby Day is currently the Chief Operating Officer at Biomebank since 2023.
Prior to this, he worked as a Principal at Myriad Genetics, Inc. and as the VP, General Manager-Research & Development at Arteriocyte Medical Systems, Inc. Mr. Day has a graduate degree from Case Western Reserve University and an undergraduate degree from Southern Utah University.
Postes actifs de Kolby Day
| Sociétés | Poste | Début |
|---|---|---|
Biomebank
 Biomebank BiotechnologyHealth Technology Biomebank is an Australian clinical stage biotechnology company that aims to prevent diseases by restoring gut microbial ecology through microbiome-based therapies. The company is based in Thebarton, Australia. Biomebank's product is the world's first approved microbiome-based therapy for the treatment of recurrent and refractory clostridioides difficile infection. The company was founded by Rob Bryant and Sam Costello, with Sam Costello serving as the CEO since incorporation. | Directeur des opérations | 29/08/2023 |
Anciens postes connus de Kolby Day
| Sociétés | Poste | Fin |
|---|---|---|
| MYRIAD GENETICS, INC. | Corporate Officer/Principal | - |
Arteriocyte Medical Systems, Inc.
 Arteriocyte Medical Systems, Inc. Medical SpecialtiesHealth Technology Arteriocyte Medical Systems, Inc. develops and markets novel medical products. The firms products include Magellan, Magellan PRP, mar0max, mar0match and mar0fuse. It divisions include compass biomedical and discover truPRP. The company was founded in 2007 and is headquartered in Hopkinton, MA. | Directeur Technique/Scientifique/R&D | - |
Formation de Kolby Day
| Southern Utah University | Undergraduate Degree |
| Case Western Reserve University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MYRIAD GENETICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Arteriocyte Medical Systems, Inc.
Arteriocyte Medical Systems, Inc. Medical SpecialtiesHealth Technology Arteriocyte Medical Systems, Inc. develops and markets novel medical products. The firms products include Magellan, Magellan PRP, mar0max, mar0match and mar0fuse. It divisions include compass biomedical and discover truPRP. The company was founded in 2007 and is headquartered in Hopkinton, MA. | Health Technology |
Biomebank
Biomebank BiotechnologyHealth Technology Biomebank is an Australian clinical stage biotechnology company that aims to prevent diseases by restoring gut microbial ecology through microbiome-based therapies. The company is based in Thebarton, Australia. Biomebank's product is the world's first approved microbiome-based therapy for the treatment of recurrent and refractory clostridioides difficile infection. The company was founded by Rob Bryant and Sam Costello, with Sam Costello serving as the CEO since incorporation. | Health Technology |
